CASI Pharmaceuticals
CASI
#7804
Rank
$44.22 M
Marketcap
$3.30
Share price
0.30%
Change (1 day)
42.86%
Change (1 year)

Earnings for CASI Pharmaceuticals (CASI)

Earnings in 2023 (TTM): -$26.3 M

According to CASI Pharmaceuticals's latest financial reports the company's current earnings (TTM) are -$26.3 M. In 2022 the company made an earning of -$37.44 M a decrease over its 2021 earnings that were of -$35.85 M.The earnings displayed on this page is the company's Pretax Income.

Earnings history for CASI Pharmaceuticals from 2001 to 2023

Annual earnings

Year Earnings Change
2023 (TTM) -$26.3 M-29.76%
2022 -$37.44 M4.43%
2021 -$35.85 M-24.56%
2020 -$47.52 M4.74%
2019 -$45.37 M65.13%
2018 -$27.48 M155.07%
2017 -$10.78 M13.93%
2016 -$9.46 M31.18%
2015 -$7.21 M-72.5%
2014 -$26.21 M356.62%
2013 -$5.74 M-60.55%
2012 -$14.55 M218.41%
2011 -$4.57 M0.74%
2010 -$4.54 M-32.54%
2009 -$6.73 M-66.98%
2008 -$20.36 M-14.22%
2007 -$23.74 M7.04%
2006 -$22.18 M27.95%
2005 -$17.33 M4.51%
2004 -$16.58 M-15.84%
2003 -$19.7 M-55.29%
2002 -$44.07 M-34.05%
2001 -$66.82 M